| Ticker Details |
CorMedix Inc.
Cormedix Inc is a commercial-stage biopharmaceutical company. It focuses on development and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases.
|
| IPO Date: |
May 13, 2010 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$542.07M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.14 | 4.07%
|
| Avg Daily Range (30 D): |
$0.28 | 2.69%
|
| Avg Daily Range (90 D): |
$0.29 | 2.62%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.62M |
| Avg Daily Volume (30 D): |
3.43M |
| Avg Daily Volume (90 D): |
2.83M |
| Trade Size |
| Avg Trade Size (Sh.): |
199 |
| Avg Trade Size (Sh.) (30 D): |
141 |
| Avg Trade Size (Sh.) (90 D): |
125 |
| Institutional Trades |
| Total Institutional Trades: |
881 |
| Avg Institutional Trade: |
$1.46M |
| Avg Institutional Trade (30 D): |
$1.29M |
| Avg Institutional Trade (90 D): |
$1.41M |
| Avg Institutional Trade Volume: |
.14M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.86M |
| Avg Closing Trade (30 D): |
$2.14M |
| Avg Closing Trade (90 D): |
$2.07M |
| Avg Closing Volume: |
188.91K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$2.26
|
$1.42
|
$.29
|
|
Diluted EPS
|
$2.08
|
$1.26
|
$.28
|
|
Revenue
|
$214.3M
|
$104.28M
|
$39.74M
|
|
Gross Profit
|
$198.47M
|
$93.08M
|
$37.87M
|
|
Net Income / Loss
|
$162.5M
|
$108.56M
|
$19.83M
|
|
Operating Income / Loss
|
$103.95M
|
$51.35M
|
$19.54M
|
|
Cost of Revenue
|
$12.3M
|
$7.57M
|
$1.86M
|
|
Net Cash Flow
|
$14.09M
|
$-109.93M
|
$93.02M
|
|
PE Ratio
|
3.56
|
|
|
|
|
|
